title: Management of acute loss of asthma control in the yellow zone: a practice parameter.
authors: Chitra
authors: C
authors: Dinakar
authors: John
authors: J
authors: Oppenheimer
authors: Jay
authors: J
authors: Portnoy
authors: Leonard B
authors: LB
authors: Bacharier
authors: James
authors: J
authors: Li
authors: Carolyn M
authors: CM
authors: Kercsmar
authors: David
authors: D
authors: Bernstein
authors: Joann
authors: J
authors: Blessing-Moore
authors: David
authors: D
authors: Khan
authors: David
authors: D
authors: Lang
authors: Richard
authors: R
authors: Nicklas
authors: Christopher
authors: C
authors: Randolph
authors: Diane
authors: D
authors: Schuller
authors: Sheldon
authors: S
authors: Spector
authors: Stephen A
authors: SA
authors: Tilles
authors: Dana
authors: D
authors: Wallace
mesh_terms: D000085:Acetates / Q000627:therapeutic use; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D058666:Adrenergic beta-2 Receptor Agonists / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy* / Q000628:therapy; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D003521:Cyclopropanes; D006801:Humans; D020024:Leukotriene Antagonists / Q000627:therapeutic use; D009330:Nebulizers and Vaporizers; D011804:Quinolines / Q000627:therapeutic use; D012141:Respiratory Tract Infections / Q000628:therapy; D012648:Self Care / Q000379:methods*; D013440:Sulfides
chemical_list: D000085:Acetates; D000305:Adrenal Cortex Hormones; D058666:Adrenergic beta-2 Receptor Agonists; D001993:Bronchodilator Agents; D003521:Cyclopropanes; D020024:Leukotriene Antagonists; D011804:Quinolines; D013440:Sulfides; C093875:montelukast